This switch from production of gamma-globins to beta-globin has been studied intensively because production of sufficient amounts of HbF in erythroid cells of patients with sickle cell anemia or beta-thalassemia can ameliorate many of the clinical symptoms of these diseases (15). The gene discussed is HBB; the disease is sickle cell disease.